Antibiotic alkylating agent

0 marketed 2 in Phase 3

This page covers all Antibiotic alkylating agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting DNA.

Targets

Phase 3 pipeline (2)

Mitomycin (MM) · University of Sydney · Oncology
Mitomycin is an antibiotic that alkylates DNA, causing cross-linking and strand breaks that prevent cell division and induce apoptosis.
Mitomycin for Injection · Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Oncology
Mitomycin is an antibiotic that alkylates DNA, creating cross-links that prevent DNA replication and transcription, leading to cell death.